Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk

Circulation Journal

Volumn 78, Issue 7, 2014, Pages 1600-1605

  Numa, Satoshi ^a   Hirai, Tadakazu ^a   Nakagawa, Keiko ^a   Ohara, Kazumasa ^a   Fukuda, Nobuyuki ^a   Nozawa, Takashi ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Nonvalvular atrial fibrillation; Thromboembolic risk; Transesophageal echocardiography; Uric acid

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CHADS2 SCORE; CREATININE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; URIC ACID BLOOD LEVEL; ATRIAL FIBRILLATION; BLOOD; CLINICAL TRIAL; COMPLICATION; ECHOGRAPHY; FEMALE; MIDDLE AGED; RISK FACTOR;

URIC ACID;

ADULT; AGED; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM; URIC ACID;

EID: 84903170180     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1385     Document Type: Article

References (31)

1. Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE; the ATRIA Study Group. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 2008; 51: 810-815.
2. Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Kumagai N, et al; J-RHYTHM Registry Investigators. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: Results of the J-RHYTHM Registry. Circ J 2013; 77: 2264-70.
3. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
4. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
5. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med 2004; 164: 1546-1551.
6. Valbusa F, Bertolini L, Bonapace S, Zenari L, Zoppini G, Arcaro G, et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 2013; 112: 499-504.
7. Sakabe M, Fujiki A, Sakamoto T, Nakatani Y, Mizumaki K, Inoue H. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Electrophysiol 2012; 23: 1130-1135.
8. Sasahara E, Nakagawa K, Hirai T, Takashima S, Ohara K, Fukuda N, et al. Clinical and transesophageal echocardiographic variables for prediction of thromboembolic events in patients with nonvalvular atrial fibrillation at low-intermediate risk. J Cardiol 2012; 60: 484-488.
9. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998; 128: 639-647.
10. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969.
11. Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR. Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic study. J Am Coll Cardiol 1996; 27: 95-101.
12. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992: National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-2410.
13. Sezai A, Soma M, Nakata K, Hata M, Yoshitake I, Wakui S, et al. Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH Trial). Circ J 2013; 77: 2043-2049.
14. Nyrnes A, Toft I, Njølstad I, Mathiesen EB, Wilsgaard T, Hansen JB, et al. Uric acid is associated with future atrial fibrillation: An 11-year follow-up of 6308 men and women: The Tromsø Study. Europace 2014; 16: 320-326.
15. Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2012; 76: 607-611.
16. Wang H, Jacobs DR Jr, Gaffo AL, Gross MD, Goff DC Jr, Carr JJ. Longitudinal association between serum urate and subclinical atherosclerosis: The Coronary Artery Risk Development in Young Adults (CARDIA) study. J Intern Med 2013; 274: 594-609.
17. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
18. Nakagawa K, Hirai T, Takashima S, Fukuda N, Ohara K, Sasahara E, et al. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. Am J Cardiol 2011; 107: 912-916.
19. Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, et al; ROCKET AF Steering Committee and Investigators. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: Validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 2013; 127: 224-232.
20. Fatkin D, Loupas T, Low J, Feneley M. Inhibition of red cell aggregation prevents spontaneous echocardiographic contrast formation in human blood. Circulation 1997; 96: 889-896.
21. Iwama M, Kawasaki M, Tanaka R, Ono K, Watanabe T, Hirose T, et al. Left atrial appendage emptying fraction assessed by a featuretracking echocardiographic method is a determinant of thrombus in patients with nonvalvular atrial fibrillation. J Cardiol 2012; 59: 329-336.
22. Wysokinski WE, Ammash N, Sobande F, Kalsi H, Hodge D, McBane RD. Predicting left atrial thrombi in atrial fibrillation. Am Heart J 2010; 159: 665-671.
23. Bernhardt P, Schmidt H, Hammerstingl C, Lüderitz B, Omran H. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk: A prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 2005; 45: 1807-1812.
24. Di Tullio MR, Homma S, Jin Z, Sacco RL. Aortic atherosclerosis, hypercoagulability, and stroke: The APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol 2008; 52: 855-861.
25. Ward RP, Don CW, Furlong KT, Lang RM. Predictors of long-term mortality in patients with ischemic stroke referred for transesophageal echocardiography. Stroke 2006; 37: 204-208.
26. Doukky R, Gage H, Nagarajan V, Demopoulos A, Cena M, Garcia-Sayan E, et al. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography 2013; 30: 889-895.
27. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369: 283-292.
28. Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Stroke and thromboembolism in atrial fibrillation. Circ J 2012; 76: 2289-2304.
29. Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, et al. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score=0 in a community-based cohort study. J Cardiovasc Electrophysiol 2012; 23: 708-713.
30. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study. BMJ 2011; 342: d124, doi:10.1136/bmj.d124.
31. Stöckl D, Döring A, Thorand B, Heier M, Belcredi P, Meisinger C. Reproductive factors and serum uric acid levels in females from the general population: The KORA F4 study. PLoS One 2012; 7: e32668, doi:10.1371/journal.pone.0032668.